Evaxion Biotech A/S (EVAX) NASDAQ
4.05
+0.01(+0.25%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.05
+0.01(+0.25%)
Currency In USD
| Market Cap | 30.57M |
| Enterprise Value | 14.84M |
| P/E Ratio | -3.36 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 3.39 |
| Price/Book Ratio | 1.52 |
| Enterprise/Revenue | 1.3 |
| Enterprise/EBITDA | -1.14 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.02 |
| Operating Margin | -1.23 |
| Return On Assets | -0.27 |
| Return On Equity | -0.62 |
| Revenue | 7.55M |
| Revenue/Share | 1.18 |
| Gross Profit | 7.53M |
| EBITDA | -8.65M |
| Net Income | -7.73M |
| Diluted EPS | -1.21 |
| Total Cash | 23.23M |
| Total Cash/Share | 3.63 |
| Total Debt | 7.5M |
| Total Debt/Equity | 0.44 |
| Current Ratio | 5.85 |
| Book Value Per Share | 2.66 |
| 52-Week Change | 185.21 |
| 52-Week High | 12.15 |
| 52-Week Low | 1.25 |
| Moving Average 50 Days | 3.53 |
| Moving Average 200 Days | 4.15 |
| Average Volume | 45,390 |
| Shares Outstanding | 6.32M |
| % Held by Institutions | 15.81 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | January 14, 2025 |